Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer

Clinical trial NCT07046078 · RECRUITING

Trial details

NCT number: NCT07046078
Sponsor: Fred Hutchinson Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Leukemia of Ambiguous Lineage Acute Myeloid Leukemia Chronic Myelomonocytic Leukemia Myelodysplastic Syndrome

Start date: 2025-09-26
Primary completion: 2027-06-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.